Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?
- 15 May 2001
- journal article
- Vol. 164 (10), 1413-9
Abstract
Influenza and pneumococcal pneumonia are serious health problems among elderly people and a major cause of death in long-term care facilities. We describe the results of serial surveys of vaccination coverage and influenza outbreak management in Canadian long-term care facilities over the last decade. Cross-sectional surveys consisting of questionnaires mailed to all Canadian residential long-term care facilities for elderly people in 1991 and to a random sample of respondents in 1995 and 1999. The response rates were 83% (430/515) in 1995 and 75% (380/506) in 1999. In 1999 the mean reported rates of influenza vaccination were 83% among residents and 35% among staff, and the mean rate of pneumococcal vaccination among residents was 71%; all 3 rates were significantly higher than those in 1991. The rates were also higher in facilities with an infection control practitioner than in those without such an individual (88% v. 82% for influenza vaccination among residents [p < 0.001], 42% v. 35% for influenza vaccination among staff [p = 0.008] and 75% v. 63% for pneumococcal vaccination among residents [p < 0.001]). Obtaining consent for vaccination on admission to the facility was associated with higher influenza and pneumococcal vaccination rates among residents (p = 0.04 and p < 0.001 respectively). Facilities with higher influenza vaccination rates among residents and staff reported lower rates of influenza outbreaks (p = 0.08 and 0.03 respectively). Despite recommendations from the National Advisory Committee on Immunization, only 50% of the facilities had policies for amantadine prophylaxis during influenza A outbreaks. Amantadine was judged effective in controlling 76% of the influenza A outbreaks and was discontinued because of side effects in 3% of the residents. Influenza and pneumococcal vaccination rates among residents and staff in Canadian long-term care facilities have increased over the last decade but remain suboptimal. Vaccination of residents and staff against influenza is associated with a reduced risk of influenza outbreaks. Amantadine is effective in controlling influenza outbreaks in long-term care facilities.This publication has 39 references indexed in Scilit:
- Effectiveness of Live, Attenuated Intranasal Influenza Virus Vaccine in Healthy, Working AdultsJAMA, 1999
- Influenza Vaccination in Long-Term–Care Facilities: Structuring Programs for SuccessInfection Control & Hospital Epidemiology, 1999
- Effectiveness of Influenza Vaccine in Health Care ProfessionalsJAMA, 1999
- Clinical Efficacy of Pneumococcal Vaccine in the ElderlyAmerican Journal Of Medicine, 1997
- Influenza Vaccination of Health Care Workers in Long-Term-Care Hospitals Reduces the Mortality of Elderly PatientsThe Journal of Infectious Diseases, 1997
- The Effectiveness of Vaccination against Influenza in Healthy, Working AdultsNew England Journal of Medicine, 1995
- Influenza and Pneumococcal Vaccination in Canada and the United States, 1980-1993: What Can the Two Countries Learn from Each Other?Clinical Infectious Diseases, 1995
- Influenza and Pneumococcal Vaccination and Tuberculin Skin Testing Programs In Long-Term Care Facilities: Where Do We Stand?Infection Control & Hospital Epidemiology, 1995
- Efficacy of Pneumococcal Vaccination in AdultsArchives of Internal Medicine, 1994
- Efficacy of Pneumococcal Vaccine in High-Risk PatientsNew England Journal of Medicine, 1986